Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial.

@article{Duggan2004GlutamineSI,
  title={Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial.},
  author={Christopher P Duggan and Ann R. Stark and Nancy Auestad and Sharon Collier and Jill Fulhan and Kathleen M. Gura and Sherri Utter and Armando Teixeira-Pinto and Kate E. Donovan and Dennis Lund},
  journal={Nutrition},
  year={2004},
  volume={20 9},
  pages={752-6}
}
OBJECTIVE Glutamine (Gln) is a non-essential amino acid that plays an important role in energy metabolism for gastrointestinal epithelia and other cells with rapid turnover. We evaluated the effects of enteral supplementation with Gln in infants undergoing surgery for congenital or acquired gastrointestinal disease. METHODS This was a randomized, double-masked, controlled clinical trial. RESULTS Twenty infants were randomly assigned to receive Gln (n = 9) or placebo amino acid (n = 11… CONTINUE READING